 Connection
David Moreno to Biomarkers
This is a "connection" page, showing publications David Moreno has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.128 |
|
|
|
-
Moreno DF, Nadeu F, Brasó-Maristany F, Vaqué S, Paz S, Mañé J, Cardús O, Medina E, Lozano E, Rodríguez-Lobato LG, de Daniel A, Tovar N, Cibeira MT, Bladé J, Rosiñol L, Prat A, Colomer D, Fernández de Larrea C. Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P. Front Immunol. 2025; 16:1604089.
Score: 0.102
-
Moreno-Castaño AB, Fernández S, Brillembourg H, Iraola G, Moreno DF, Ventosa-Capell H, Martinez-Sanchez J, De Moner B, Molina P, Ramos A, Palomo M, Gómez-Ramírez P, Ortiz-Maldonado V, Martínez-Cibrián N, Delgado J, Oliver-Caldés A, Fernández de Larrea C, Salas MQ, Urbano Á, Téllez A, Nicolás JM, Juan M, González-Navarro A, Penack O, Escolar G, Carreras E, Fernández-Avilés F, Castro P, Diaz-Ricart M. m-EASIX (better than EASIX) predicts severe CAR T-cell toxicities, worse overall survival, and discriminates cytokine release syndrome from sepsis. Front Immunol. 2025; 16:1664788.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|